#AAN2018 – Rituxan a Promising First-line Immunotherapy in Late-onset MG, Study Suggests – Myasthenia Gravis News
Myasthenia Gravis News |
#AAN2018 – Rituxan a Promising First-line Immunotherapy in Late-onset MG, Study Suggests
Myasthenia Gravis News The researchers analyzed Rituxan’s effectiveness and safety by treating six late-onset MG patients (five women and one man) with the therapy, ultimately evaluating its potential as a first-line immunotherapy. Mean age of myasthenia gravis onset was 66 … |
Business Wire (press release) |
Ferring Gains Option to FKD’s Phase III Bladder Cancer Gene Therapy Candidate
Genetic Engineering & Biotechnology News Ferring Pharmaceuticals said today it has acquired the option to secure global commercialization rights to FKD Therapies’ Phase III bladder cancer gene therapy candidate nadofaragene firadenovec/Syn3 (rAd-IFN/Syn3), through an agreement whose value was … Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer PatientsBusiness Wire (press release) Ferring commits to US oncology and cutting-edge researchThe Pharma Letter |
Express.co.uk |
Stem cell biological BREAKTHROUGH as scientists craft embryo without egg or sperm
Mirror.co.uk Scientists have announced a biological breakthrough by growing an embryo without either a sperm or an egg. Using two different types of stem cells, a team of researchers controversially grew them into the early stages of a human being in a petri dish … Scientists build ‘synthetic embryos’ – BBC NewsBBC News Cloning horror: Human clone fears as Euro scientists CREATE LIFE from ‘nothing’Express.co.uk Scientists Use Stem Cells To Create Embryo Without Sperm Or EggLADbible Phys.Org –The Japan Times all 14 news articles » |